ArticleFrontiers in oncology2025
Evaluating the effectiveness of integrated care in targeted therapy for patients with chronic lymphocytic leukemia.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: For patients with chronic lymphocytic leukemia (CLL), the type of nursing care during targeted therapy may significantly impact treatment efficacy and quality of life. This study evaluated the effects of routine care and comprehensive care on biomarkers, treatment response, and patient-reported outcome measures (PROMs) in patients with CLL undergoing targeted therapy. Methods: A total of 260 patients with CLL were enrolled, with 150 receiving routine care and 110 receiving comprehensive care. Baseline characteristics of the two groups were compared, and differences in biomarkers at diagnosis were assessed. Multivariable logistic regression models were used to analyze the impact of baseline information and care methods on treatment response. Generalized estimating equations (GEE) were used to evaluate trends in PROMs (SF-36, ECOG, and HADS scores) over the follow-up period. Results: Baseline analysis showed no significant differences between the two groups in terms of age, gender, smoking, alcohol consumption, comorbidities, and Rai stage. Drug response analysis showed that age, diabetes, Rai stage and nursing mode significantly affected the treatment effect. Comprehensive nursing significantly increased the effectiveness of targeted drug therapy and reduced the risk of disease progression. During the follow-up period, the lymphocyte count, white blood cell count, ESR, β2-microglobulin, and LDH levels of patients in the comprehensive nursing group significantly decreased, while immunoglobulin levels significantly increased. In addition, comprehensive nursing significantly improves patients' quality of life, improves physical fitness, reduces anxiety and depression levels, especially in the six months and one year after treatment. Conclusion: Comprehensive care significantly improved treatment outcomes, reduced disease progression, and enhanced the quality of life in patients with CLL undergoing targeted therapy, making it suitable for long-term management of patients with CLL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.